Lineage (LINE) Form 4: Director receives 4,490 RSUs, no shares sold
Rhea-AI Filing Summary
Lineage, Inc. (LINE) filed a Form 4 that records a routine equity-compensation event for board member Michael John Turner. On 18 June 2025 the director was awarded 4,490 time-based restricted stock units (RSUs) at a $0 acquisition price. Each unit converts one-for-one into common stock and vests fully on the earlier of 18 June 2026 or the company’s next annual shareholder meeting, conditional on Mr. Turner’s continued service. Following the grant he now beneficially owns 7,122 common shares held directly. No insider sales, cash purchases, or derivative transactions were reported, and the filing contains no indications of changes in control or governance concerns. Overall, the disclosure appears to be a standard component of Lineage’s director compensation program.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine RSU grant; negligible valuation impact.
The 4,490-share RSU award adds only a modest stake relative to Lineage’s expected float, signalling neither bullish nor bearish sentiment. With no insider selling and a zero-cost basis, the filing is best viewed as standard board remuneration that marginally tightens share alignment but carries no material effect on earnings, liquidity, or near-term stock performance.
TL;DR: Follows typical board-pay practice; governance neutral.
The RSUs vest after one year or at the next AGM—an industry-standard cadence aimed at retention and alignment. No 10b5-1 plan is flagged, yet the award size and terms appear proportionate, posing no dilution or pay-for-performance red flags. Consequently, the event is considered normal course and not impactful to governance risk assessments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,490 | $0.00 | -- |
Footnotes (1)
- [object Object]